Just days into Australia’s rollout of its CCP virus vaccination strategy, two elderly people in an aged care home in the state of Queensland have been given four times the correct dosage of the Pfizer/BioNTech vaccine.
The 88-year-old man and 94-year-old woman, both residents at the Holy Spirit Nursing Home in Brisbane, the state’s capital, are being monitored but have not shown signs of an adverse reaction at this stage.
However, Nine News political reporter Johnathan Kearsley told Nine’s Today morning show on Wednesday morning that, as he understood, the elderly man is in hospital.
Kearsley noted that Queensland Premier Annastacia Palazczuk and the federal government will likely address the issue over the course of the morning.
The doctor responsible for the overdoses has resigned.
Health Minister Greg Hunt said the deputy chief medical officer would review the events and file a report.
“Significantly the patients themselves are showing, at this point, on the latest advice that I have, five minutes before joining us, absolutely no adverse reaction,” he told reporters in Canberra on Wednesday. “The rollout continues. There will be cases. There will be challenges. This has happened in other jurisdictions overseas.”
The Therapeutic Goods Administration cleared the Pfizer/BioNTech vaccine for use in elderly Australians but noted that for frail patients over the age of 85, the TGA had limited research data on its effects, and it should be carefully assessed on a case-by-case basis.
The TGA’s statement on this came after 30 out of 40,000 elderly people in Norway died after receiving the Pfizer/BioNTech vaccine.
“The deaths were recorded among very frail patients, including some who were anticipated to only have weeks or months to live,” TGA said on Feb. 2.
A recent Department of Health survey of 4,000 people showed that 27 percent of Australians were hesitant about receiving the vaccine, preferring to wait to see if side effects emerge in others.